Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients with COVID-19 is limited.

Matéria Original


Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents


Quinoline and Quinazoline Derivatives Inhibit Viral RNA Synthesis by SARS-CoV-2 RdRp